期刊文献+

细胞色素P4502C8和细胞色素P4502J2基因多态性与中国汉族散发性阿尔茨海默病的相关性研究

Relationship between genetic polymorphisms of cytochrome P4502C8 and cytochrome P4502J2 with the risk of Alzheimer's disease in Chinese Han population
原文传递
导出
摘要 目的:探讨细胞色素P450氧化酶(CYP)2C8和2J2基因多态性与中国汉族散发性阿尔茨海默病( AD)的相关性。方法收集206例AD患者及256例健康对照的外周血标本,用全血基因组的提取试剂盒提取基因组的DNA,采用基质辅助激光解吸电离飞行时间质谱( MALDI-TOF-MS)的方法,对CYP2C8(rs1058932,rs2275622)、CYP2J2(rs1155002,rs2271800)基因多态性进行检测。结果候选4个多态性的基因型和等位基因的频率分布在2组间比较差异均无统计学意义( P>0.05)。分别对CYP2C8/2J2的两个SNPs位点构建单体型, CYP2C8的单体型 C -T 与 AD 组呈正相关( P <0.001, OR =2.57,95%CI:1.97~3.35)。结论 CYP2C8(rs1058932,rs2275622)单体型C-T增加了中国汉族散发性AD的发病风险。 Objective To detect the association between cytochrome P450 2C8 ( CYP2C8 ) and CYP2C9 polymorphisms and the risk of Alzheimer′s disease ( AD ) in Chinese Han population.Methods A case-control study was carried out to compare the distribution of geno-types and genetic frequencies of CYP2C8 and CYP2C9 polymorphisms between Alzheimer′s disease ( n =206 ) and healthy volunteers ( n=256 ) .Genomic DNA was extracted from whole blood using DNA blood Kit.Matrix-assisted laser desorption ionization time-of -flight mass spectrometry ( MALDI-TOF-MS) .Matrix-assisted laser desorp-tion ionization time-of-flight mass spectrometry ( MALDI-TOF-MS) was used to identify the polymorphisms of CYP2C8 and CYP2J2. Results There were no significant differences of CYP2C8 and CYP2C9 genotypes between the cases and control groups.The haplotype C-T of CYP2C8 associated with the AD group( P〈0.001,OR=2.57,95%CI:1.97 -3.35 ) .Conclusion The haplotype C -T of CYP2C8 ( rs1058932, rs2275622 ) increased the risk of Alzheimer′s disease in Chinese Han population.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2015年第11期924-927,共4页 The Chinese Journal of Clinical Pharmacology
基金 国家自然科学基金资助项目(81100945) 广州市珠江科技新星专项基金资助项目(2013J2200027)
关键词 阿尔茨海默病 细胞色素P4502C8 细胞色素P4502J2:基因多态性 Alzheimer's disease cytochrome P4502C8 cytochromeP4502J2 genetic polymorphism
  • 相关文献

参考文献9

  • 1Querfurth HW, LaFerla FM. Alzheimer's disease[ J]. N Engl J Med, 2010,362 : 329 - 344.
  • 2Amor S, Puentes F, Baker D, et al. Inflammation in neurodegenera- tive diseases [ J ]. Immunology, 2010,129 : 154 - 169.
  • 3Mandrekar - Colucci S, Landreth GE. Microglia and inflammation in Alzheimer's disease[ J]. CNS Neurol Disord Drug Targets, 2010,9 : 156 - 167.
  • 4Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases [ J ]. Nat Rev Drug Discov, 2009, 8:794 - 805.
  • 5Rao JS, Rapoport SI, Kim HW. Altered neuroinflammatory, arachi- donic acid cascade and synaptic markers in postmortem Alzheimer's disease brain [ J ]. Translt Psychiatry, 2011,1 : 1 - 9.
  • 6Dutheil F, Beanne P, Lofiot MA. Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome PdSO en- zymes in normal and pathological human brain [ J ]. Biochimie, 2008,90:426 - 436.
  • 7Nishimura M, Yaguti H, Yosbitsugu H, et al. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high - sensitivity real - time reverse transcription PCR [ J ]. Yaku- gaku Zasshi, 2003,123:369 -375.
  • 8Duthcil F, Dauchy S, Diry M, et al. Xenobiotic - metabolizing en- zymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function [ J]. Drug Metab Dispos, 2009,37 : 1528 - 1538.
  • 9Salminen A, Ojala J, Kauppinen A, et al. Inflammation in Alzhei- mer's disease: amyloid- beta oligomers trigger innate immunity de- fence via pattern recognition receptors [ J ]. Prog Neurobiol, 2009, 87:181 - 194.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部